Editor's note: This story was updated at 7:54 p.m. on Feb. 14 to include more details about Phi Gamma Delta infractions and violations. This story was updated at 10:22 p.m. on Feb. 14 to include ...
ADI-001 is an allogeneic gamma delta CAR T-cell therapy that targets the B-cell antigen CD20. The Food and Drug Administration (FDA) has granted Fast Track designation to ADI-001 for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback